Related Experiment Video
Updated: Jul 7, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
E1a gene expression blocks the ERK1/2 signaling pathway by promoting nuclear localization and MKP up-regulation:
Juan L Callejas-Valera1, Juan Guinea-Viniegra, Carmen Ramírez-Castillejo
1Centro Regional Investigaciones Biomédicas/Facultad de Medicina, Universidad de Castilla la Mancha, Albacete 02006.
Abstract:
In response to oncogenic signals, cells have developed safe mechanisms to avoid transformation through activation of a senescence program. Upon v-H-Ras overexpression, normal cells undergo senescence through several cellular processes, including activation of the ERK1/2 pathway. Interestingly, the E1a gene from adenovirus 5 has been shown to rescue cells from senescence by a yet unknown mechanism. We investigated whether E1a was able to interfere with the ERK1/2 signaling pathway to rescue cells from v-H-Ras-mediated senescence. Our results show that, E1a overexpression blocks v-H-Ras-mediated ERK1/2 activation by two different and concomitant mechanisms. E1a through its ability to interfere with PKB/Akt activation induces the down-regulation of the PEA15 protein, an ERK1/2 nuclear export factor, leading to nuclear accumulation of ERK1/2. In addition to this, we show that E1a increases the expression of the inducible ERK1/2 nuclear phosphatases (MAPK phosphatases) MKP1/DUSP1 and DUSP5, which leads to ERK1/2 dephosphorylation. We confirmed our observations in the human normal diploid fibroblasts IMR90, in which we could also show that an E1a mutant, unable to bind retinoblastoma protein (pRb), cannot rescue cells from v-H-Ras-induced senescence. In conclusion, E1a is able to rescue from Ras-induced senescence by affecting ERK1/2 localization and phosphorylation.
Insights
Adenovirus E1a protein prevents oncogene-induced senescence by blocking the ERK1/2 pathway. It affects ERK1/2 localization and phosphorylation, offering a novel mechanism for cell cycle control.
Area of Science:
- Cellular senescence
- Oncogenic signaling pathways
- Viral gene function
Background:
- Cells activate senescence programs to prevent transformation in response to oncogenic signals.
- v-H-Ras overexpression induces senescence via pathways including ERK1/2 activation.
- Adenovirus E1a gene rescues cells from senescence through an unknown mechanism.
Purpose of the Study:
- Investigate if Adenovirus E1a interferes with the ERK1/2 pathway to prevent v-H-Ras-induced senescence.
- Elucidate the molecular mechanisms by which E1a inhibits senescence.
Main Methods:
- Overexpression of v-H-Ras and Adenovirus E1a in human normal diploid fibroblasts (IMR90).
- Analysis of ERK1/2 pathway activation, localization, and phosphorylation.
- Assessment of PEA15 protein levels and MAPK phosphatase (MKP1/DUSP1, DUSP5) expression.
- Use of an E1a mutant unable to bind retinoblastoma protein (pRb).
Main Results:
- E1a overexpression blocks v-H-Ras-mediated ERK1/2 activation through two mechanisms.
- E1a interferes with PKB/Akt, down-regulates PEA15, causing ERK1/2 nuclear accumulation.
- E1a increases MKP1/DUSP1 and DUSP5 expression, leading to ERK1/2 dephosphorylation.
- An E1a mutant deficient in pRb binding failed to rescue cells from senescence.
Conclusions:
- E1a rescues cells from Ras-induced senescence by modulating ERK1/2 localization and phosphorylation.
- E1a's anti-senescence function is dependent on its interaction with pRb.
- The study reveals dual mechanisms involving PEA15 and MAPK phosphatases in E1a-mediated senescence evasion.
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules

